Madison, Wisconsin
Colorectal cancer clinical trials in Madison, WI
28 colorectal cancer studies are recruiting participants at sites in Madison as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Madison at a glance
- 28 studies are recruiting at a site in Madison.
- By phase: Phase 1 (4), Phase 1/2 (8), Phase 2 (7), Phase 2/3 (1), Phase 3 (3), Phase 4 (1), No phase (2), Observational (2). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (19), university, hospital or other (8), government (1).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Madison
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study sites
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center · University of Wisconsin Carbone Cancer Center - University Hospital
- Registry record
- NCT05863195 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- UW Health Carbone Cancer Center
- Registry record
- NCT07488676 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- University of Wisconsin
- Registry record
- NCT07659795 · updated
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Dustin Deming
- Study site
- University of Wisconsin
- Registry record
- NCT06493019 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study site
- William S Middleton VA Medical Center
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center · University of Wisconsin Carbone Cancer Center - University Hospital
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center · University of Wisconsin Carbone Cancer Center - University Hospital · William S Middleton VA Medical Center
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- University of Wisconsin Carbone Cancer Center - University Hospital
- Registry record
- NCT06418204 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of Wisconsin - Carbone Cancer Center
- Registry record
- NCT07213791 · updated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- William S. Middleton Memorial VA
- Registry record
- NCT06662786 · updated
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Univ of Wisconsin-Madison
- Registry record
- NCT07416552 · updated
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University Hospital and UW Health Clinics-Carbone Cancer Center ( Site 0293)
- Registry record
- NCT06428409 · updated
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- University of Wisconsin
- Registry record
- NCT06710756 · updated
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT06885034 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- University of Wisconsin (Carbone Cancer Center)
- Registry record
- NCT06026410 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- University of Wisconsin, Carbone Cancer Center
- Registry record
- NCT05919264 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- University of Wisconsin Carbone Cancer Center
- Registry record
- NCT04585750 · updated
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- Wisconsin Institute for Medical Research
- Registry record
- NCT06625775 · updated
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Phanes Therapeutics
- Study site
- University of Wisconsin Carbone Cancer Center - University Hospital
- Registry record
- NCT05482893 · updated
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Phase 2
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT05489211 · updated
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- University of Wisconsin, Madison
- Study site
- University of Wisconsin Carbone Cancer Center
- Registry record
- NCT05854498 · updated
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- University of Wisconsin Carbone Cancer Center - University Hospital
- Registry record
- NCT06557733 · updated
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Medtronic - MITG
- Study site
- SSM Health St. Mary's Hospital - Madison
- Registry record
- NCT07351071 · updated
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Marengo Therapeutics, Inc.
- Study site
- University of Wisconsin- Madison
- Registry record
- NCT05592626 · updated
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- University of Iowa
- Study site
- University of Wisconsin
- Registry record
- NCT05239546 · updated
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Phase 4
- Ages 18 to 64
- All sexes
- Sponsor
- Guerbet
- Study site
- University of Wisconsin
- Registry record
- NCT04373564 · updated
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Apollomics Inc.
- Study site
- University of Wisconsin
- Registry record
- NCT03175224 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Madison, WI on ClinicalTrials.gov.
Ask about studies near Madison
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections